1. Kuban P., Foret F. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. Analyt. Chim. Acta 2013; 805: 1–18.

2. Анаев Э.Х., Чучалин А.Г. Исследование конденсата выдыхаемого воздуха в пульмонологии (обзор). Пульмонология 2002; 2: 57–66.

3. Hunt J. Exhaled breath condensate: an overview. Immunol. Allergy Clin. N. Am. 2007; 27: 587–596.

4. Scheideler L., Manke H.-G., Schwulera U. et al. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am. Rev. Respir. Dis. 1993; 148 (3): 778–784.

5. Анаев Э.Х., Чучалин А.Г. Конденсат выдыхаемого воздуха в диагностике и оценке эффективности лечения болезней органов дыхания. Пульмонология 2006; 4: 12–20.

6. Moloney E., Mumby S., Gajdocsi R. et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am. J. Respir. Crit. Care Med. 2004; 169: 64–69.

7. Shahid S., Kharitonov S., Wilson N. et al. Increased interleukin4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am. J. Respir. Crit. Care Med. 2002; 165: 1290–1293.

8. Gessner C., Rechner B., Hammerschmidt S. et al. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 2010; 68 (2): 177–184.

9. Barak V., Goike H., Panaretakis K., Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin. Biochem. 2004; 37: 529–540.

10. Lai R.-S., Chen C.-C., Lee P.-C., Lu J.-Y. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion. Jpn J. Clin. Oncol. 1999; 29 (9): 421–424.

11. Paganuzzi M., Onetto M., Marroni P. et al. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest 2001; 119: 1138–1142.

12. Zhang H., Zhao Q., Chen Y. et al. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 2008; 63: 352–359.

13. Kurova V., Anaev E., Kononikhin A. et al. Proteomics of exhaled breath: methodological nuances and pitfalls. Clin. Chem. Lab. Med. 2009; 47: 706–712.

14. Kurova V., Kurochkin I., Kalamkarov G. et al. Structural and catalytic polymorphism of human enzymes: Novel potential platforms for biomedical diagnostics. Biotechnol. Adv. 2009; 27 (6): 945–959.

15. Курова В., Кононихин А., Попов И. и др. Масс-спектрометрический мониторинг белкового состава конденсата выдыхаемого воздуха больного, перенесшего трансплантацию легких. Изв. РАН. Сер. хим. 2010; 59 (1): 292–296.

16. Курова В., Кононихин А., Попов И. и др. Экзогенные белки в конденсате выдыхаемого человеком воздуха. Биоорган. химия 2011; 37 (1): 55–60.

17. Ishihama Y., Rappsilber J., Andersen J.S., Mann M. Microcolumns with self-assembled particle frits for proteomics. J. Chromatogr. A 2002; 979 (1–2): 233–239.

18. Nesvizhskii A., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Analyt. Chem. 2003; 75 (17): 4646–4658.

19. Hoffmann H., Tabaksblat L., Enghild J., Dahl R. Human skin keratins are the major proteins in exhaled breath condensate. Eur. Respir. J. 2008; 31: 380–384.

20. Poschmann G., Sitek B., Sipos B. et al. Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol. Cell. Proteomics 2009; 8 (5): 1105–1116.

21. Spik I., Brenuchon C., Angeli V. et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J. Immunol. 2005; 174: 3703–3708.

22. Wei N., Deng X.W. The COP9 signalosome. Ann. Rev. Cell. Dev. Biol. 2003; 19: 261–286.

23. Wood L., Maher J., Bunton T., Resar L. The oncogenic properties of the HMG-I gene family. Cancer Res. 2000; 60: 4256–4261.

24. Resar L. The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res. 2010; 70: 436–439.

25. Walmer D., Padin C., Wrona M. et al. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res. 1995; 55: 1168–1175.

26. Ziolkowski P., Wozniak M., Dus K., Wisniewski J. The NUCKS: A novel tumor biomarker. J. Mol. Biomark. Diagn. 2013; 4: 3.